Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RandomizEd compariSOn of Apixaban Versus Warfarin in Patients With Left VEntricular Thrombus After Acute Myocardial Infarction (RESOLVE-AMI)

NCT06515730 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT06515730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06515730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RandomizEd compariSOn of Apixaban Versus Warfarin in Patients With Left VEntricular Thrombus After Acute Myocardial Infarction (RESOLVE-AMI)
Lead sponsor
Karolinska Institutet
Phase
Phase 4
Overall status
Recruiting
Start date
April 8, 2025
Completion date
July 1, 2028
Enrollment
212 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction, left ventricular thrombus